1型EBV与2型EBV:在伯基特淋巴瘤中NK细胞抗瘤活性的一个决定因素
bioRxiv : the preprint server for biology
|February 23, 2026
概括
终端分化的CD56阴性,CD16阳性自然杀手 (NK) 细胞表现出抗体依赖细胞细胞毒性 (ADCC),但效率低于CD56模糊NK细胞. EBV类型影响NK细胞对伯基特淋巴瘤的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- 在慢性感染和伯基特淋巴瘤 (BL) 中观察到终端分化的CD56阴性,CD16阳性 (CD56negCD16pos) 自然杀手 (NK) 细胞.
- 这些NK细胞具有细胞毒性颗粒和Fc-γ受体,这表明抗体依赖细胞细胞毒性 (ADCC) 的潜力,尽管直接细胞毒性较低.
- CD56negCD16pos NK细胞的丰度与IgG1和IgG3水平相关,这对ADCC至关重要.
研究的目的:
- 为了比较CD56negCD16posNK细胞与CD56dimNK细胞的ADCC能力.
- 为了研究爱斯坦-巴尔病毒 (EBV) 类型对NK细胞介导的ADCC对BL细胞系的影响.
主要方法:
- 在肯尼亚,使用儿科癌症患者和健康儿童的效应细胞进行了ADCC测定.
- 目标细胞包括在实验室中接受西马布治疗的商业和新建立的BL细胞系 (EBV-Type 1和EBV-Type 2).
- 测量NK细胞脱粒化 (CD107a表达),以评估ADCC活性.
主要成果:
- CD56阴性CD16阳性NK细胞在体外表现出ADCC活性,由Rituximab增加的CD107a脱粒度表明.
- 然而,与CD56dimNK细胞相比,CD56negCD16posNK细胞在ADCC中效率较低.
- 针对EBV-Type 2 BL线的ADCC大小明显低于EBV-Type 1 BL线,因为EBV-T2细胞表达更多的性病毒蛋白,并且更容易受到直接细胞毒性.
结论:
- CD56negCD16pos NK细胞有助于ADCC,但它们的效果不如CD56dim NK细胞那么强.
- EBV类型显著影响NK细胞介导的BL细胞的杀死;EBV-T2 BL细胞更容易被消除.
- NK介导免疫疗法的临床结果取决于患者特定的NK细胞概况,ADCC敏感度和瘤细胞内的EBV类型.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Immune Response Against Viral Pathogens
2.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K


